Chromonics

submitted by: icamvid

Chromonics by Dr. Oleg D. Lavrentovich, Kent State University

Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans

submitted by: sjokeefe
Background: Epidemiologic studies have suggested that most cases of sporadic colon cancer can be attributed to diet. The recognition that colonic microbiota have a major influence on colonic health suggests that they might mediate colonic carcinogenesis. Objective: To examine the hypothesis that the influence of diet on colon cancer risk is mediated by the microbiota through their metabolites, we measured differences in colonic microbes and their metabolites in African Americans with a...
Authors: Junhai Ou, Franck Carbonero, Erwin G Zoetendal, James P DeLany, Mei Wang, Keith Newton, H Rex Gaskins, Stephen JD O’Keefe

Informatics

submitted by: Dongjia

Informatics C.Barnes, D.Chen, L.Zhu

Why Choose Skaggs?

submitted by: Sarah Ross

Final for Bioinformatics.

Grape Powder Supplementation Prevents Oxidative Stress–Induced Anxiety-Like Behavior, Memory Impairment, and High Blood Pressure in Rats

submitted by: ssalim
We examined whether or not grape powder treatment ameliorates oxidative stress–induced anxiety-like behavior, memory impairment, and hypertension in rats. Oxidative stress in Sprague-Dawley rats was produced by using L-buthionine- (S,R)-sulfoximine (BSO). Four groups of rats were used: 1) control (C; injected with vehicle and provided with tap water), 2) grape powder–treated (GP; injected with vehicle and provided for 3 wk with 15 g/L grape powder dissolved in tap water), 3)...
Authors: Farida Allam, An Dao, Gaurav Chugh, Ritu Bohat, Faizan Jafri, Gaurav Patki, Christopher Mowrey, Mohammad Asghar, Karim Alkadhi, Samina Salim

The New Oral Anticoagulants in Clinical Practice

submitted by: WentzMR
Dr. Wilson Gonsalves, a Hematology Fellow, and Dr. Mrinal Patnaik, an Assistant Professor of Hematology and Oncology at Mayo Clinic in Rochester, MN, share data from their manuscript appearing in the May 2013 issue of Mayo Clinic Proceedings on the development of 3 new alternatives to the anticoagulant, Warfarin, that promise fewer food/drug interactions and do not require therapeutic monitoring. Available at: http://tinyurl.com/bnrxc2c